Clinical Trial: Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases.

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733193) titled 'Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases.' on July 23.

Brief Summary: Radiation therapy is a common treatment for painful bone metastases, proving effective in 1 to 2/3 of cases after 1 to 10 sessions, with stereotactic body radiation therapy (SBRT) likely offering superior results.

Radiation therapy is also used to prevent bone events, although its use is not standardized; the decision to administer it is made by clinicians or through multidisciplinary team (MDT) discussions.

Recently, it has been shown that preventive radiation therapy can reduce the risk of skeletal-related events (SREs) in...